kras mutation and glutathion JCI Uncovering new therapeutic targets for
Uncovering new therapeutic targets for a common KRAS mutation behind cancer Interplays of glucose metabolism and KRAS mutation in pancreatic ductal adenocarcinoma Cell Death & Disease Targeting mutated GTPase KRAS in tumor therapies ScienceDirect Targeting KRAS Mutant Cancers with a Covalent G12C Specific Inhibitor: Cell
Pay in 4 interest-free payments of $7.10 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6



